Hacker News new | ask | show | jobs
by bgribble 851 days ago
> and quadrupled the survival at 36 months compared to placebo-chemotherapy

There are lots of ways to slice the data. I think the one I quote is probably what got the researchers so excited.

The problem is that the 36-month survival is pretty low, so even quadrupling it only increases the average survival time by the 1.6 months or whatever.

Mesothelioma is one of the worst. My mom died of it at age 53, which is way too young.

1 comments

When the heart-strings aren't being tugged, most people aren't totally stupid, and can understand basic statistics and probability distributions well enough, but those things are never given freely to the public when it comes to oncology. I can get a bell curve on different brands of hard drives or fuel injectors easily enough, but on a costly intervention that leads to much "collateral damage", that information is all behind a paywall in literal Greek. This is not an "oopsie". This is intentional.